Get the Stockscreener App
14.19
8.16%
-1.26
After Hours:
14.19
Nurix Therapeutics Inc Stock (NRIX) Latest News
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Receives $31.81 Average Price Target from Analysts - MarketBeat
(NRIX) Trading Report - Stock Traders Daily
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Shares Sold by ARK Investment Management LLC - MarketBeat
Oversold Conditions For Nurix Therapeutics (NRIX) - Nasdaq
Allspring Global Investments Holdings LLC Decreases Stock Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Allspring Global Investments Holdings LLC Reduces Stock Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - Defense World
Analysts Predict How High Nurix Therapeutics Inc (NRIX) Will Go. - Stocks Register
Kymera Therapeutics: Plenty Of Potential, But A Long Way From The Finish Line (KYMR) - Seeking Alpha
Nurix Therapeutics: A Story To Monitor (NASDAQ:NRIX) - Seeking Alpha
Nurix Therapeutics (NRIX) to Release Quarterly Earnings on Thursday - Defense World
Sumitomo Mitsui Trust Group Inc. Has $14.87 Million Holdings in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Nurix Therapeutics (NRIX) Projected to Post Earnings on Thursday - MarketBeat
Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Strategic Equity Package: Nurix Therapeutics Secures Top Talent with $8.2M Employee Stock Awards - StockTitan
Sumitomo Mitsui Trust Group Inc. Raises Stock Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - Defense World
Nurix Therapeutics (NRIX) Projected to Post Quarterly Earnings on Thursday - Defense World
Nurix Therapeutics Inc [NRIX] Investment Appeal on the Rise - Knox Daily
Nurix Therapeutics Reports Third Quarter Fiscal 2023 Financial Results and Provides a Corporate Update - br.ADVFN.com
Nurix Therapeutics Reports First Quarter Fiscal 2023 Financial Results and Provides a Corporate Update - br.ADVFN.com
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Receives $31.12 Consensus Price Target from Brokerages - MarketBeat
Nurix Therapeutics (NASDAQ:NRIX) Stock Price Expected to Rise, Morgan Stanley Analyst Says - MarketBeat
There is no doubt that Nurix Therapeutics Inc (NRIX) ticks all the boxes. - SETE News
Trading Day Triumph: Nurix Therapeutics Inc (NRIX) Ends at 18.59, a -1.90 Surge/Plunge - The Dwinnex
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
Morgan Stanley Forecasts Strong Price Appreciation for Nurix Therapeutics (NASDAQ:NRIX) Stock - Defense World
NRIX (Nurix Therapeutics Inc) may reap gains as insiders became active recently - Knox Daily
HC Wainwright Expects Lower Earnings for Nurix Therapeutics - MarketBeat
Nurix Therapeutics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference - The Manila Times
Nurix Therapeutics Officer Sells Shares - TradingView
Nurix Therapeutics, Inc. (NASDAQ:NRIX) CFO Houte Hans Van Sells 2,811 Shares - MarketBeat
Balanced Outlook on Nurix Therapeutics: Hold Rating Amidst Promising Trials and Uncertainties - TipRanks
Nurix Therapeutics (NRIX) – Research Analysts’ Weekly Ratings Changes - Defense World
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Insider Gwenn Hansen Sells 3,690 Shares - MarketBeat
Nurix Therapeutics (NASDAQ:NRIX) Price Target Raised to $27.00 at Royal Bank of Canada - MarketBeat
Nurix Therapeutics (NASDAQ:NRIX) Given New $36.00 Price Target at Stifel Nicolaus - MarketBeat
Nurix Therapeutics' SWOT analysis: protein degrader stock's potential - MSN
Nurix Therapeutics (NASDAQ:NRIX) Price Target Raised to $36.00 at HC Wainwright - MarketBeat
Needham & Company LLC Cuts Nurix Therapeutics (NASDAQ:NRIX) Price Target to $28.00 - MarketBeat
JPMorgan Chase & Co. Issues Pessimistic Forecast for Nurix Therapeutics (NASDAQ:NRIX) Stock Price - MarketBeat
SG Americas Securities LLC Buys 7,141 Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX) - Defense World
Q1 EPS Estimate for Nurix Therapeutics Reduced by Analyst - Defense World
6.45%
1.23%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):